2,000
Participants
Start Date
September 1, 2023
Primary Completion Date
May 28, 2024
Study Completion Date
October 23, 2024
GSK's liquid oral live attenuated HRV
2 doses of GSK's liquid oral live attenuated HRV study intervention administered orally at Day 1 and Month 1, according to the immunization schedule for HRV study intervention licensed outside of China.
PCV-free liquid formulation of GSK's oral live attenuated HRV
2 doses of PCV-free liquid formulation of GSK's oral live attenuated HRV study intervention administered orally at Day 1 and Month 1, according to the immunization schedule for HRV study intervention licensed outside of China.
GSK Investigational Site, Mianyang
GSK Investigational Site, Nanbu-Nanchong
GSK Investigational Site, Neijiang
GSK Investigational Site, Wenshan
GSK Investigational Site, Honghe
GSK Investigational Site, Wenshan
GSK Investigational Site, Dali
GSK Investigational Site, Baoshan
GSK Investigational Site, Baoshan
GSK Investigational Site, Baoshan
GSK Investigational Site, Tengchong
GSK Investigational Site, Mianyang
Lead Sponsor
GlaxoSmithKline
INDUSTRY